About AROMASIN NORDIC FUSION
Aromasin Nordic Fusion is a laboratory-grade exemestane formulation designed for in-vitro research applications studying aromatase enzyme inhibition and estrogen biosynthesis pathways. Exemestane is a steroidal aromatase inhibitor that irreversibly binds to the aromatase enzyme (CYP19A1), effectively blocking the conversion of androgens to estrogens in research models. This mechanism makes it a valuable tool for investigating hormone-dependent cellular processes and endocrine pathway modulation. Researchers at Stroid UK Shop utilise exemestane compounds to examine estrogen receptor signalling, breast cancer cell biology, and reproductive endocrinology mechanisms in controlled laboratory environments.
Laboratory Applications
Research scientists investigate exemestane in studies examining estrogen-dependent cellular proliferation, hormone receptor expression patterns, and endocrine disruption models. The compound serves as a reference standard for aromatase inhibition research, allowing examination of estrogen synthesis blockade effects on various cell lines and tissue cultures. Studies evaluate its irreversible binding characteristics compared to reversible inhibitors like anastrozole, providing insights into different inhibition mechanisms. Researchers also examine exemestane’s metabolic pathways, investigating how its androgenic metabolite 17-hydroxyexemestane affects cellular responses. This compound proves particularly valuable in cancer biology research, where scientists study estrogen-dependent tumour growth inhibition and examine potential therapeutic mechanisms in hormone-sensitive malignancies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Exemestane |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Purity Grade | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Mechanism | Irreversible aromatase inhibition |
| Research Classification | Steroidal aromatase inhibitor |
Researchers studying complementary pathways often examine exemestane alongside selective androgen receptor modulators to understand hormone receptor crosstalk mechanisms. Additionally, scientists investigate interactions with peptide hormones to examine comprehensive endocrine system responses in experimental models.
Research Compliance
This exemestane formulation is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and institutional approvals when conducting studies with this compound.
